To compare the effects of two drugs used in brachial plexus block in upper limb surgery
Phase 4
- Conditions
- Health Condition 1: S50-S59- Injuries to the elbow and forearm
- Registration Number
- CTRI/2018/09/015694
- Lead Sponsor
- AIIMS Raipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Sixty patients aged 18 to 60 years, ASA physical status Iâ??II, scheduled for upper limb and hand surgery under supraclavicular brachial plexus block with 0.5% levobupivacaine, will be recruited.
Exclusion Criteria
a)Patients with contraindications for brachial plexus block
b)ASA grade III and above
c)Known allergy to any of the study medications
d)Acute or chronic respiratory disease
e)Hypertension or Cardiovascular abnormalities
f)Patients receiving adrenoceptor agonist or antagonist or chronic analgesic therapy
g)Diabetes Mellitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Onset time and Duration of Motor and Sensory blocks.Timepoint: Sensory and Motor blocks will be evaluated every 5 minutes until 20 minutes after injection, and then 30 min after surgery, until the block resolves.
- Secondary Outcome Measures
Name Time Method Adverse events such as sedation, hypotension, bradycardiaTimepoint: HR, SBP, DBP and SpO2 will be recorded at 0 min, 1 min, 5 min, 10 min and then after every 10 min intervals during the surgery and then hourly for the next 24 hours